RxDoctor Payments Data

Robert Bunge, MD

Psychiatry · Lexington, KYNPI 1396727079

Payments from drug & device makers

$1,060in general payments, 2019–2025

Across 82 payments — averaging $12.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$431
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$131
  • Otsuka America Pharmaceutical, Inc.$110
  • Sunovion Pharmaceuticals Inc.$85
  • Johnson & Johnson$43
  • Supernus Pharmaceuticals, Inc.$41
  • plus $220 from 10 others

What the payments were for

  • Food & beverage$1,03097%
  • Education$303%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,060 in reported general payments places this provider in the 65th percentile of 348 psychiatry providers in Kentucky.

See all psychiatry providers in Kentucky

Medicare billing

Part B allowed, 2024
$27,689
Medicare patients
91
Services billed
380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl25$35,199
AuvelityDextromethorphan Hbr/Bupropion20$30,649
EmsamSelegiline11$27,345
Lurasidone Hcl58$22,412
Lamictal OdtLamotrigine13$11,994
Aripiprazole113$10,580
Chlorpromazine Hcl20$8,330
Asenapine Maleate31$7,496
Ondansetron Hcl19$6,616
Desvenlafaxine Succinate ErDesvenlafaxine Succinate60$5,680
Duloxetine Hcl307$5,417
Lamotrigine OdtLamotrigine21$4,541
Alprazolam589$4,242
Bupropion XlBupropion Hcl181$4,106
Dextroamphetamine Sulfate22$4,010

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$431$35,19925 claims
Axsome Therapeutics, Inc.Auvelity$32$30,64920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 348 psychiatry providers in Kentucky.

Other psychiatry in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →